| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |